Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa

被引:8
|
作者
Seltzer, Janyla A. [1 ]
Okeke, Chidubem A. V. [1 ]
Perry, Jessica D. [1 ]
Shipman, William D. [2 ]
Okoye, Ginette A. [3 ]
Byrd, Angel S. [3 ]
机构
[1] Howard Univ, Coll Med, Washington, DC USA
[2] Weill Cornell Rockefeller Sloan Kettering Triinst, 1300 York Ave,C-103, New York, NY 10065 USA
[3] Howard Univ, Coll Med, Dept Dermatol, Washington, DC USA
关键词
D O I
10.1016/j.jaad.2020.05.012
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
下载
收藏
页码:E153 / E154
页数:2
相关论文
共 50 条
  • [31] Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases
    Bachiller-Corral, Javier
    Boteanu, Alina
    Jesus Garcia-Villanueva, Maria
    de la Puente, Carlos
    Revenga, Marcelino
    Consuelo Diaz-Miguel, M.
    Rodriguez-Garcia, Ana
    Luis Morell-Hita, Jose
    Valero, Marta
    Larena, Carmen
    Blazquez-Canamero, Maria
    Guillen-Astete, Carlos A.
    Garrote, Sandra
    Sobrino, Cristina
    Medina-Quinones, Carmen
    Vazquez-Diaz, Monica
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1098 - 1102
  • [32] COVID-19 in multiple sclerosis patients and risk factors for severe infection
    Chaudhry, Farhan
    Bulka, Helena
    Rathnam, Anirudha S.
    Said, Omar M.
    Lin, Jia
    Lorigan, Holly
    Bernitsas, Eva
    Rube, Jacob
    Korzeniewski, Steven J.
    Memon, Anza B.
    Levy, Phillip D.
    Schultz, Lonni
    Javed, Adil
    Lisak, Robert
    Cerghet, Mirela
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 418
  • [33] Metformin use and risk for COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Kuntz, Jennifer
    Floyd, James
    Walker, Rod
    Fortmann, Stephen
    Bayliss, Elizabeth
    Shortreed, Susan
    Harrington, Laura
    Lee, Mi
    Albertson-Junkans, Ladia
    Powers, John
    Fuller, Sharon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 506 - 506
  • [34] Updated findings from the global hidradenitis suppurativa COVID-19 registry
    Naik, Haley B.
    Alhusayen, Raed
    Guilbault, Sandra
    Ingram, John
    Lowes, Michelle A.
    Marzano, Angelo V.
    Villumsen, Bente
    Yannuzzi, Christine
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 55 - 55
  • [35] May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa?
    Caro, Raffaele D. Caposiena
    Pensa, Chiara
    Lambiase, Sara
    Candi, Eleonora
    Bianchi, Luca
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (05) : 616 - 617
  • [36] May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa?
    Caro, Raffaele Dante Caposiena
    Pensa, Chiara
    Lambiase, Sara
    Candi, Eleonora
    Bianchi, Luca
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 95 - 95
  • [37] Clozapine treatment and risk of severe COVID-19 infection
    Ohlis, Anna
    Wallin, Alma Sorberg
    Sarafis, Anna
    Sjoqvist, Hugo
    MacCabe, James H.
    Ahlen, Johan
    Dalman, Christina
    ACTA PSYCHIATRICA SCANDINAVICA, 2022, 145 (01) : 79 - 85
  • [38] COVID-19 vaccine immunity in hidradenitis suppurativa patients receiving TNF-alpha inhibitors
    Nosrati, A.
    Torpey, M. E.
    Ball, G. D.
    Shokrian, N.
    Campton, K. L.
    Cohen, S. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B12 - B12
  • [39] Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab
    Sandhu, Gagangeet
    Piraino, Samuel T.
    Piticaru, Joshua
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (03) : E275 - E278
  • [40] COVID-19 and treatment with biologics: Safety insights from the phase 3 studies of secukinumab in patients with moderate-to-severe hidradenitis suppurativa
    Muscianisi, Elisa
    Potocki, Anne-Christine
    Keefe, Deborah
    Thomas, Nicolas
    Kasparek, Torben
    Kimball, Alexa B.
    Gottlieb, Alice B.
    Alavi, Afsaneh
    Reguiai, Ziad
    Jemec, Gregor B. E.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 77 - 78